Your Article Summary
Are We Optimizing Gestational Diabetes Treatment With Glyburide? The Pharmacologic Basis for Better Clinical Practice
Clinical Pharmacology & Therapeutics, 03/19/09
Hebert MF et al. - Despite comparable beta-cell responsivity indices, the average beta-cell function corrected for insulin resistance was more than 3.5-fold lower in women with glyburide-treated GDM than in healthy pregnant women. Women with GDM in whom glyburide treatment has failed may benefit from alternative medication or dosage escalation; however, fetal safety should be kept in mind.
Today in Physician/Patient Trends...keeping you current
Receive free subspecialty "5-minute updates" via email
Predicting age at onset of menopause: Testing the "adaptive onset" hypothesis
Maturitas, 11/11/09
Trends in prescribing and self-poisoning in relation to UK regulatory authority warnings against use of SSRI antidepressants in under-18-year-olds
British Journal of Clinical Pharmacology, 11/02/09
Urinary Diversion Trends at a High Volume, Single American Tertiary Care Center
The Journal of Urology, 11/02/09
Article Search
Sponsor


See Latest Articles


